BSE Live
Sep 08, 12:56Prev. Close
340.25
Open Price
340.55
Bid Price (Qty.)
344.45 (20)
Offer Price (Qty.)
345.05 (79)
NSE Live
Sep 08, 12:56Prev. Close
340.20
Open Price
341.35
Bid Price (Qty.)
344.90 (5)
Offer Price (Qty.)
345.00 (154)
Key Financial Ratios of Advanced Enzyme Technologies (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 9.16 | 9.67 | 4.97 | 4.88 | 6.36 | |
Diluted EPS (Rs.) | 9.15 | 9.66 | 4.97 | 4.87 | 6.35 | |
Cash EPS (Rs.) | 10.17 | 10.64 | 5.89 | 5.73 | 7.16 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 56.25 | 51.91 | 46.98 | 42.97 | 38.97 | |
Book Value [InclRevalReserve]/Share (Rs.) | 56.25 | 51.91 | 46.98 | 42.97 | 38.97 | |
Dividend / Share(Rs.) | 5.20 | 5.10 | 1.00 | 1.00 | 0.90 | |
Revenue from Operations/Share (Rs.) | 31.41 | 32.68 | 27.86 | 24.40 | 25.37 | |
PBDIT/Share (Rs.) | 11.81 | 14.67 | 7.57 | 7.31 | 9.62 | |
PBIT/Share (Rs.) | 10.79 | 13.69 | 6.65 | 6.46 | 8.82 | |
PBT/Share (Rs.) | 10.77 | 11.98 | 6.64 | 6.45 | 8.81 | |
Net Profit/Share (Rs.) | 9.15 | 9.67 | 4.97 | 4.88 | 6.36 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 37.61 | 44.87 | 27.18 | 29.95 | 37.90 | |
PBIT Margin (%) | 34.36 | 41.89 | 23.88 | 26.45 | 34.75 | |
PBT Margin (%) | 34.29 | 36.66 | 23.84 | 26.41 | 34.72 | |
Net Profit Margin (%) | 29.14 | 29.58 | 17.82 | 19.98 | 25.05 | |
Return on Networth / Equity (%) | 16.27 | 18.62 | 10.56 | 11.34 | 16.30 | |
Return on Capital Employed (%) | 18.75 | 25.82 | 13.80 | 14.62 | 21.97 | |
Return on Assets (%) | 14.87 | 17.08 | 9.64 | 10.29 | 14.51 | |
Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover Ratio (%) | 0.53 | 0.60 | 0.56 | 0.54 | 57.94 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 5.19 | 6.21 | 5.13 | 4.87 | 3.91 | |
Quick Ratio (X) | 2.92 | 3.79 | 3.04 | 2.66 | 2.36 | |
Inventory Turnover Ratio (X) | 1.50 | 1.61 | 1.55 | 1.57 | 4.47 | |
Dividend Payout Ratio (NP) (%) | 55.68 | 51.71 | 20.13 | 18.45 | 9.43 | |
Dividend Payout Ratio (CP) (%) | 50.10 | 46.97 | 16.99 | 15.70 | 8.38 | |
Earnings Retention Ratio (%) | 44.32 | 48.29 | 79.87 | 81.55 | 90.57 | |
Cash Earnings Retention Ratio (%) | 49.90 | 53.03 | 83.01 | 84.30 | 91.62 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 3,114.50 | 3,867.35 | 2,565.71 | 3,136.08 | 3,851.46 | |
EV/Net Operating Revenue (X) | 8.86 | 10.58 | 8.24 | 11.50 | 13.59 | |
EV/EBITDA (X) | 23.56 | 23.58 | 30.29 | 38.37 | 35.85 | |
MarketCap/Net Operating Revenue (X) | 8.88 | 10.63 | 8.32 | 11.56 | 13.59 | |
Retention Ratios (%) | 44.31 | 48.28 | 79.86 | 81.54 | 90.56 | |
Price/BV (X) | 4.96 | 6.69 | 4.93 | 6.57 | 8.85 | |
Price/Net Operating Revenue | 8.88 | 10.63 | 8.32 | 11.56 | 13.59 | |
Earnings Yield | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 |
05.08.2025
Advanced Enzyme Consolidated June 2025 Net Sales at Rs 185.91 crore, up 20.31% Y-o-Y
05.08.2025
Advanced Enzyme Standalone June 2025 Net Sales at Rs 125.02 crore, up 45.45% Y-o-Y
13.05.2025
Advanced Enzyme Standalone March 2025 Net Sales at Rs 87.21 crore, down 5.62% Y-o-Y
13.05.2025
Advanced Enzyme Consolidated March 2025 Net Sales at Rs 167.18 crore, up 5.93% Y-o-Y